VVM

Versant Venture Management Portfolio holdings

AUM $82.1M
1-Year Return 26.22%
This Quarter Return
+11.38%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$82.1M
AUM Growth
+$21.9M
Cap. Flow
+$13.8M
Cap. Flow %
16.74%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

1
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
+$15.2M

Top Sells

1
CTNM
Contineum Therapeutics
CTNM
+$1.49M
2
TPST icon
Tempest Therapeutics
TPST
+$7

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GLUE icon
1
Monte Rosa Therapeutics
GLUE
$400M
$25.5M 31.04%
5,652,922
– –
CRSP icon
2
CRISPR Therapeutics
CRSP
$5.57B
$24.2M 29.52%
498,558
– –
JBIO
3
Jade Biosciences, Inc. Common Stock
JBIO
$233M
$15.2M 18.56%
+1,525,820
New +$15.2M
SKYE icon
4
Skye Bioscience
SKYE
$120M
$8.39M 10.22%
2,007,704
– –
RPTX icon
5
Repare Therapeutics
RPTX
$74.7M
$3.68M 4.48%
2,646,657
– –
CTNM
6
Contineum Therapeutics
CTNM
$333M
$2.15M 2.62%
542,628
-375,535
-41% -$1.49M
TPST icon
7
Tempest Therapeutics
TPST
$44.7M
$1.83M 2.23%
269,772
-1
-0% -$7
ADVM icon
8
Adverum Biotechnologies
ADVM
$63.4M
$1.09M 1.33%
506,821
– –